Literature DB >> 14518571

Does this patient have Alzheimer disease? Diagnosing and treating dementia.

Barbara J Messinger-Rapport1.   

Abstract

Alzheimer disease follows a pattern of gradual cognitive, behavioral, and functional decline. Other causes of dementia have overlapping presentations, but with important differences. Most patients with mild to moderate dementia should be treated with cholinesterase inhibitors to temporarily stabilize symptoms and delay clinically important end points. Memantine, an N-methyl-D-aspartate antagonist, may soon be available to treat moderate to severe dementia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14518571     DOI: 10.3949/ccjm.70.9.762

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  1 in total

1.  Clinical evaluation of patients with moderate to severe Alzheimer disease.

Authors:  Paulo Rogério Borges Rosmaninho Varandas; Rossana Russo Funari
Journal:  Dement Neuropsychol       Date:  2007 Jul-Sep
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.